In this study, we assessed the clinical value of three SNPs CD40 (rs1883832), BAFFR (rs7290134), and LTβR (rs10849448) in NSCLC, with the results further supporting previous findings from our and other groups on the role of these molecules in NSCLC. This evidence concerns the gene CD40 and non-small cell lung carcinoma.